Page 23 - Celularity Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celularity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celularity Inc Today - Breaking & Trending Today

Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene's Best-in-Class Bispecific Antibody with Celularity's Natural Killer Cell Platform

Published: July 19, 2022

- This research collaboration marks Antengene's entry into the field of cellular medicines. SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ --Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that it has entered intoa pre-clinical research collaboration with Celularity Inc. (NASDAQ: CELU) (Celularity), a clinical-stage biotechnology company developing ...

Source: singaporestar.com

Celularity (NASDAQ:CELU) & Kezar Life Sciences (NASDAQ:KZR) Critical Comparison

Published: July 14, 2022

Celularity (NASDAQ:CELU – Get Rating) and Kezar Life Sciences (NASDAQ:KZR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Celularity and Kezar […]

Source: etfdailynews.com